Phase I/IIA Study with CNS-Targeted Liposomal Doxorubicin (2B3-101) in Patients with Brain Metastases (BM) From Breast Cancer (BC) and Other Brain Tumors
Philippe Aftimos(Institut Jules Bordet), Dieta Brandsma(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Véronique Dièras(Institut Curie), Agnes Jager(Erasmus MC Cancer Institute), Mónica Arnedos, Patricia M.M.B. Soetekouw(Radboud University Nijmegen), Sevilay Altıntaş(Antwerp University Hospital), A. J. Gelderblom(Leiden University Medical Center), Myra van Linde(Amsterdam UMC Location Vrije Universiteit Amsterdam), Carey K. Anders(Duke University)
Cited by 4
Related Papers
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
|Annals of Oncology|2018|1.2k